1-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole
98%
- Product Code: 238479
CAS:
1424857-63-5
Molecular Weight: | 665.65 g./mol | Molecular Formula: | C₃₆H₄₂Cl₂N₄O₄ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, Inert Gas |
Product Description:
Used in research and development of pharmaceutical formulations targeting central nervous system disorders. Shows potential in enhancing drug delivery due to improved solubility and controlled release properties. Investigated for its role in treating psychiatric conditions such as schizophrenia and bipolar disorder by modulating dopamine and serotonin receptors. Also explored for better pharmacokinetic profiles compared to parent compounds. Not approved for clinical use; currently limited to laboratory and preclinical studies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.025 | 10-20 days | $11,907.84 |
+
-
|
1-[4-[(1,2,3,4-Tetrahydro-2-oxo-7-quinolinyl)oxy]butyl] Aripiprazole
Used in research and development of pharmaceutical formulations targeting central nervous system disorders. Shows potential in enhancing drug delivery due to improved solubility and controlled release properties. Investigated for its role in treating psychiatric conditions such as schizophrenia and bipolar disorder by modulating dopamine and serotonin receptors. Also explored for better pharmacokinetic profiles compared to parent compounds. Not approved for clinical use; currently limited to laboratory and preclinical studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :